-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 26, Tigermed disclosed its 2021 semi-annual report.
During the reporting period, the company achieved operating income of RMB 2.
056 billion, a year-on-year increase of 41.
62%; net profit attributable to shareholders of listed companies was RMB 1.
255 billion, a year-on-year increase of 25.
65%; The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 543 million yuan, a year-on-year increase of 79.
10%; the net cash inflow from operating activities was 484 million yuan, a year-on-year increase of 120.
10%
.
The company signed a new order of 5.